United States - English - NLM (National Library of Medicine)

dna labs, inc. - bos taurus adrenal gland (unii: m2776swb29) (bos taurus adrenal gland - unii:m2776swb29), agrimonia eupatoria (unii: ebu0u94820) (agrimonia eupatoria - unii:ebu0u94820), bellis perennis (unii: 2hu33i03uy) (bellis perennis - unii:2hu33i03uy), camphor (natural) (unii: n20hl7q941) (camphor (natural) - unii:n20hl7q941), matricaria chamomilla (unii: g0r4ubi2zz) (matricaria chamomilla - unii:g0r4ubi2zz), equisetum hyemale (unii: 59677rxh25) (equisetum hyemale - unii:59677rxh25), fraxinus americana bark (uni - bos taurus adrenal gland 6 [hp_x] in 1 ml - constitutional treatment of inhalant allergies.

Australia - English - Department of Health (Therapeutic Goods Administration)

bio concepts pty ltd - taurine, quantity: 500 mg - tablet, uncoated - excipient ingredients: magnesium stearate; calcium hydrogen phosphate dihydrate; crospovidone; silicon dioxide; povidone; microcrystalline cellulose - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support natural liver cleansing/detoxification processes ; maintain/support eye health ; maintain/support cardiovascular system health ; helps maintain/support healthy heart function ; maintain/support healthy cardiovascular system function ; aid/assist/helps digestion of fats/fatty acids/triglycerides/lipid ; maintain/support bile production ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; maintain/support general mental wellbeing ; maintain/support nervous system health ; maintain/support nervous system function

Philippines - English - FDA (Food And Drug Administration)

n/a; distributor: n/a - multivitamins , lysine , taurine (vet.) - syrup (caramel flavor) - formulation: each 5 ml contains: retinyl palmitate(vitamin a)-3636 iu cholecalciferol (vitamin d3)-500 iu ascorbic acid (vitamin c)-100 mg niacinamide (vitamin b1)-57 mg riboflavin phosphate (vitamin b2)-10mg thiamine hydrochloride (vitamin b1)-5mg pyridoxine hydrochloride (vitamin b6)-5mg cyanocobalamin (vitamin b12)-1ug taurine-200 mg lysine (as hydrochloride) -40mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

tauropharm gmbh -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - midostaurin - capsule - 25mg

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - midostaurin -

Australia - English - Department of Health (Therapeutic Goods Administration)

tauropharm australia pty ltd - 57875 - non-antibiotic-based antimicrobial catheter lock solution - the device contains anticoagulants and antimicrobial substances. it is to be used with a port or a catheter-based vascular access device. it is to be instilled in the device lumens between treatments in order to make the internal flow passages resistant to clot formation and hostile to bacterial and fungal growth. the solution must be withdrawn prior to initiating the next treatment. taurolock-hep100 is indicated for those patients who use a port or a silicone or polyurethane catheter-based device as vascular access and is intended to be used as a catheter lock solution. it is to be instilled into the device at the termination of a treatment and withdrawn prior to initiating subsequent treatments.

Australia - English - Department of Health (Therapeutic Goods Administration)

tauropharm australia pty ltd - 57875 - non-antibiotic-based antimicrobial catheter lock solution - the device contains anticoagulants and antimicrobial substances. it is to be used with a port or a catheter-based vascular access device. it is to be instilled in the device lumens between treatments in order to make the internal flow passages resistant to clot formation and hostile to bacterial and fungal growth. the solution must be withdrawn prior to initiating the next treatment. taurolock-hep500 is indicated for those patients who use a port or a silicone or polyurethane catheter-based device as vascular access and is intended to be used as a catheter lock solution. it is to be instilled into the device at the termination of a treatment and withdrawn prior to initiating subsequent treatments.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - midostaurin 25mg - soft gelatin capsule - 25 mg - active: midostaurin 25mg excipient: corn oil, ethoxylated dl-alpha tocopherol ethanol gelatin glycerol iron oxide red iron oxide yellow macrogol 400 peg-40 castor oil purified water red printing ink (catalent) titanium dioxide - rydapt® is indicated: · in combination with standard anthracycline and cytarabine induction and cytarabine consolidation chemotherapy, followed in patients in complete response by single agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukemia (aml) who are flt3 mutation-positive · for the treatment of adult patients with aggressive systemic mastocytosis (asm), systemic mastocytosis with associated haematological neoplasms (sm-ahn), or mast cell leukaemia (mcl).

Australia - English - Department of Health (Therapeutic Goods Administration)

nutriforce pty ltd - taurine -